MLLT11/AF1q boosts oncogenic STAT3 activity through Src-PDGFR tyrosine kinase signaling. - sprookjes - yvandenbroek - TriplyDB

MLLT11/AF1q boosts oncogenic STAT3 activity through Src-PDGFR tyrosine kinase signaling.

MLLT11/AF1q boosts oncogenic STAT3 activity through Src-PDGFR tyrosine kinase signaling.

http://www.wikidata.org/entity/Q37536748

about

Involvement of AF1q/MLLT11 in the progression of ovarian cancer AF1q Mediates Tumor Progression in Colorectal Cancer by Regulating AKT Signaling.Novel Src/Abl tyrosine kinase inhibitor bosutinib suppresses neuroblastoma growth via inhibiting Src/Abl signaling.Receptor tyrosine kinases (RTKs) in breast cancer: signaling, therapeutic implications and challenges.Aryl Hydrocarbon Receptor Promotes IL-10 Expression in Inflammatory Macrophages Through Src-STAT3 Signaling Pathway Serum cytokine levels in breast cancer patients during neoadjuvant treatment with bevacizumab Novel AF1q/MLLT11 favorably affects imatinib resistance and cell survival in chronic myeloid leukemia

P2860

Q33618652-566372AE-BBD4-4E92-BEC1-D3C6695563B2 Q33755044-C2F65E03-F42E-4495-B6E6-882F8B5D3AE0 Q37702115-DDF2E13D-7618-4F42-892E-323DF28872A2 Q49887925-C8D848A5-AEE9-4AD2-95D8-0131645EE93F Q57072736-A6DEBE85-178B-4D52-AB67-618086C8EE98 Q58130125-6FBF9A53-38A5-4084-924E-A0A200EEF1B5 Q58699510-92A5FE40-7445-4F4B-97E6-1FAE9A72F9C1

P2860

MLLT11/AF1q boosts oncogenic STAT3 activity through Src-PDGFR tyrosine kinase signaling.

http://www.wikidata.org/entity/Q37536748

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on June 2016

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

MLLT11/AF1q boosts oncogenic STAT3 activity through Src-PDGFR tyrosine kinase signaling.

@en

MLLT11/AF1q boosts oncogenic STAT3 activity through Src-PDGFR tyrosine kinase signaling.

@nl

type

label

MLLT11/AF1q boosts oncogenic STAT3 activity through Src-PDGFR tyrosine kinase signaling.

@en

MLLT11/AF1q boosts oncogenic STAT3 activity through Src-PDGFR tyrosine kinase signaling.

@nl

prefLabel

MLLT11/AF1q boosts oncogenic STAT3 activity through Src-PDGFR tyrosine kinase signaling.

@en

MLLT11/AF1q boosts oncogenic STAT3 activity through Src-PDGFR tyrosine kinase signaling.

@nl

P1433

Q37536748-674F4596-D89F-4F46-8A9E-2CB4444A67DB

P1476

Q37536748-15852969-6B00-412C-A4B4-B46C69AD2F18

P2093

Q37536748-134D42FD-CAE5-4B90-B5B0-1B7DED8AA9A2

Q37536748-143D4A29-D1AA-4555-8177-B35C5B9EF296

Q37536748-32CB59CA-97D6-41B7-AA7A-E3EE34606325

Q37536748-38B4107E-5E55-4A54-8674-578BA58487D7

Q37536748-4B2A7616-58E5-44BF-89F4-833AF088D588

Q37536748-4CEEC7BE-FCD9-4B77-94C3-901EB99E22E5

Q37536748-6B28515A-F6E5-4401-BAF2-F3B5F5EE1F5D

Q37536748-839E599E-0B87-4718-8635-A09CBDD78C59

Q37536748-8D3B640C-6F64-49AC-9F60-6657ECF7566A

Q37536748-8FA90F63-FC90-4E70-BF8B-367EA5D5F682

P2860

Q37536748-014DACD4-031B-4C57-958E-F42B7AB098DE

Q37536748-033BD7D1-AAD0-4170-A43F-56599BF632A3

Q37536748-073F5D50-E039-4AED-AD92-96E4432A266C

Q37536748-0B01AD02-E80D-4C9F-80A3-58599BCACDA3

Q37536748-109002EC-8C80-4F79-A457-97093086CCB0

Q37536748-11157127-8E8D-4389-9BFF-F06799657F28

Q37536748-1572915C-BE89-46FB-AC55-C80954451B38

Q37536748-1C185009-C5E0-4C82-9472-B3FD70AF7CCA

Q37536748-2628CF21-BF81-43EA-A68C-CA1E89863E8B

Q37536748-2E47AB9C-E871-487D-AE3F-82ABD306C7B1

P304

Q37536748-EDCA82E3-D7A7-43D7-98FF-8B4D7EA059E8

P31

Q37536748-98BFC5EA-D503-4D0B-AE89-B7F94EF88213

P356

Q37536748-178E8A05-2C99-4D5A-BDA6-D36D1A7DBDAC

P407

Q37536748-218FDD70-07E5-4057-9500-63B650B58940

P433

Q37536748-30C40688-15AE-46C0-8B91-06216718F57F

P478

Q37536748-3FF47A30-A01D-46B8-8C7A-66CDCAA6BCF4

P50

Q37536748-02C70B89-3A3D-42A6-82B0-01DE233BBA04

Q37536748-5C5E4C15-F7C4-49BD-B774-27030AFF5C18

P577

Q37536748-0844B352-7531-41B2-8E93-61C455967A34

P698

Q37536748-9B6E73A8-358D-48F6-9803-ACCD7BB45B97

P932

Q37536748-5CA9677A-1BB6-4EF3-93B0-F73106215FE4

P356

ONCOTARGET.9759

P1433

P1476

MLLT11/AF1q boosts oncogenic STAT3 activity through Src-PDGFR tyrosine kinase signaling.

@en

P2093

Donald M Miller

http://www.w3.org/2001/XMLSchema#string

Jino Park

http://www.w3.org/2001/XMLSchema#string

Joongho Joh

http://www.w3.org/2001/XMLSchema#string

Ju-Hsien Chao

http://www.w3.org/2001/XMLSchema#string

Jun Yan

http://www.w3.org/2001/XMLSchema#string

Kevin D Bunting

http://www.w3.org/2001/XMLSchema#string

Maxwell M Krem

http://www.w3.org/2001/XMLSchema#string

Scot C Remick

http://www.w3.org/2001/XMLSchema#string

Shotaro Hagiwara

http://www.w3.org/2001/XMLSchema#string

Soojin Kim

http://www.w3.org/2001/XMLSchema#string

P2860

Oncogene AF1q enhances doxorubicin-induced apoptosis through BAD-mediated mitochondrial apoptotic pathway

Activation and association of Stat3 with Src in v-Src-transformed cell lines

R Regulation of tumor angiogenesis and metastasis by FGF and PDGF signaling pathways

The STAT3 inhibitor stattic impairs cardiomyocyte mitochondrial function through increased reactive oxygen species formation

STATs in cancer inflammation and immunity: a leading role for STAT3

Stats: transcriptional control and biological impact

The STATs of cancer--new molecular targets come of age

STATs in oncogenesis

The interplay between Eps8 and IRSp53 contributes to Src-mediated transformation.

Activation of STAT3 by the Src family kinase Hck requires a functional SH3 domain.

P304

43960-43973

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.18632/ONCOTARGET.9759

http://www.w3.org/2001/XMLSchema#string

P407

P433

28

http://www.w3.org/2001/XMLSchema#string

P478

7

http://www.w3.org/2001/XMLSchema#string

P50

Richard Moriggl

P577

2016-06-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27259262

http://www.w3.org/2001/XMLSchema#string

P932

5190071

http://www.w3.org/2001/XMLSchema#string